Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BVMF/REGN34 stock hub

BVMF/REGN34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/REGN34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

356.2B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/REGN34

In the news

Latest news · BVMF/REGN34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.7

P25 11.3P50 14.6P75 19.6

Trailing P/E15.4

P25 15.2P50 21.5P75 27.3

ROE14.5

P25 5.3P50 12.3P75 22.5

ROIC12.9

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/REGN34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	15,343
Employees Change	304%
Employees Change Percent	2.01
Enterprise value	BRL 278.7B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	BRL 356.2B
Price	BRL 59.38
Price currency	BRL
Rev Per Employee	5,072,766.1x
Sector	Healthcare
Sic	2834
Symbol	bvmf/REGN34
Website	https://www.regeneron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.48%
EV Earnings	12.08x
EV/EBIT	14.81x
EV/EBITDA	12.88x
EV/FCF	12.99x
EV/Sales	3.81x
FCF yield	6.02%
Forward P/E	13.74x
P/B ratio	2.17x
P/E ratio	15.44x
P/S ratio	4.58x
PE Ratio10 Y	22.18x
PE Ratio3 Y	19.49x
PE Ratio5 Y	16.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.76%
EBITDA Margin	29.38%
FCF margin	27.57%
Gross margin	43.89%
Gross Profit	BRL 34.2B
Gross Profit Growth	-4.75%
Gross Profit Growth Q	12.57%
Gross Profit Growth3 Y	-1.77%
Gross Profit Growth5 Y	5.15%
Net Income	BRL 23.1B
Net Income Growth	-1.69%
Net Income Growth Q	-10.08%
Net Income Growth3 Y	1.88%
Net Income Growth5 Y	2.01%
Pretax Margin	34.56%
Profit Margin	29.65%
Profit Per Employee	BRL 1.5M
ROA	6.13
Roa5y	11.91
ROCE	10.75
ROE	14.55
Roe5y	24.44
ROIC	12.93
Roic5y	28.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.97%
Cagr3y	-1.52%
Cagr5y	6.38%
EPS Growth	4.14
EPS Growth Q	-7.15
EPS Growth3 Y	3.75
EPS Growth5 Y	3.17
FCF Growth	32.6%
FCF Growth Q	3.98%
FCF Growth3 Y	4.02%
FCF Growth5 Y	15.18%
OCF Growth	26.8%
OCF Growth Q	3.23%
OCF Growth10 Y	12.99%
OCF Growth3 Y	5.4%
OCF Growth5 Y	14.13%
Revenue Growth	5.92x
Revenue Growth Q	19.04x
Revenue Growth3 Y	6.45x
Revenue Growth5 Y	10.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.38
Assets	BRL 213.2B
Cash	BRL 45.7B
Current Assets	BRL 89.5B
Current Liabilities	BRL 25.1B
Debt	BRL 14.1B
Debt EBITDA	BRL 0.61
Debt Equity	BRL 0.09
Debt FCF	BRL 0.66
Equity	BRL 163.9B
Interest Coverage	80.06
Liabilities	BRL 49.3B
Long Term Assets	BRL 123.7B
Long Term Liabilities	BRL 24.2B
Net Cash	BRL 82.6B
Net Cash By Market Cap	BRL 23.19
Net Cash Growth	6.12%
Net Debt EBITDA	BRL -3.61
Net Debt Equity	BRL -0.5
Net Debt FCF	BRL -3.85
Tangible Book Value	BRL 157.2B
Tangible Book Value Per Share	BRL 1,543
WACC	6.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.57
Inventory Turnover	2.66
Net Working Capital	BRL 26.4B
Quick ratio	2.84
Working Capital	BRL 68.3B
Working Capital Turnover	BRL 5.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.61%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	BRL 0.22
Dividend Years	2
Dividend Yield	0.37%
Ex Div Date	2026-02-19
Last Dividend	BRL 0.06
Payout Frequency	Quarterly
Payout Ratio	8.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.97%
200-day SMA	60
3Y total return	-4.49%
50-day SMA	64.44
50-day SMA vs 200-day SMA	50over200
5Y total return	36.23%
All Time High	111.7
All Time High Change	-46.85%
All Time High Date	2024-08-30
All Time Low	18.16
All Time Low Change	226.96%
All Time Low Date	2019-07-11
ATR	1.48
Beta	0.4
Ch YTD	-16.26
High	59.38
High52	73.33
High52 Date	2025-12-23
High52ch	-19.02%
Low	57.45
Low52	44.82
Low52 Date	2025-06-05
Low52ch	32.49%
Ma50ch	-7.85%
Price vs 200-day SMA	-1.04%
RSI	41.75
RSI Monthly	45.77
RSI Weekly	41.58
Sharpe ratio	0.32x
Sortino ratio	0.57
Total Return	5.98%
Tr YTD	-16.19
Tr1m	-9.27%
Tr1w	5.68%
Tr3m	-12.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 20B
Operating Income Growth	-3.33
Operating Income Growth Q	23.31
Operating Income Growth3 Y	-6.56
Operating Income Growth5 Y	-0.75
Operating margin	25.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,672,229%
Shares Insiders	3.83%
Shares Institutions	89.51%
Shares Qo Q	0.19%
Shares Yo Y	-5.61%
Short Ratio	4.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 16.3B
Average Volume	748.25x
Bv Per Share	1,608.4
CAPEX	BRL -4.7B
Ch1m	-9.27
Ch1w	5.68
Ch1y	3.58
Ch3m	-12.55
Ch3y	-4.93
Ch5y	35.6
Ch6m	2.45
Change	3.29%
Change From Open	3.36
Close	57.49
Days Gap	-0.07
Depreciation Amortization	2,653,668,000
Dollar Volume	15,973.2
Earnings Date	2026-04-29
EBIT	BRL 20B
EBITDA	BRL 22.9B
EPS	BRL 214
F Score	4
FCF	BRL 21.5B
FCF EV Yield	7.7x
Financing CF	-17,885,019,990
Fiscal Year End	December
Founded	1,988
Graham Number	48.63236
Graham Upside	-18.1
Income Tax	BRL 3.8B
Investing CF	-8,897,124,488
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2022-11-28
Last Split Type	Forward
Lynch Fair Value	BRL 19.23
Lynch Upside	-67.61
Ma150	62.76
Ma150ch	-5.38%
Ma20	61.6
Ma20ch	-3.6%
Net CF	-638,527,140
Open	57.45
P FCF Ratio	16.6
P OCF Ratio	13.62
Payment Date	2026-03-11
Position In Range	100
Ppne	25,878,668,620
Price Date	2026-05-06
Price EBITDA	BRL 15.58
Ptbv Ratio	2.27
Relative Volume	0.36x
Revenue	77,831,450,310x
SBC By Revenue	6.67x
Share Based Comp	5,192,728,065
Tax By Revenue	4.92x
Tax Rate	14.22%
Tr6m	2.63%
Volume	269
Z Score	6.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/REGN34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$0.22 annual per share

Payout ratio

+8.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+6.0%

Next ex-dividend date: 2026-02-19

Performance

BVMF/REGN34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/REGN34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+89.5%

Share of float held by funds and institutions

Insider ownership

+3.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/REGN34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.7

Neutral momentum band

Price vs 200-day MA

-1.0%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/REGN34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/REGN34 stock rating?

bvmf/REGN34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/REGN34 analysis?

The full report lives at /stocks/bvmf/REGN34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/REGN34?

The latest report frames bvmf/REGN34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/REGN34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.